The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.
 
Pieternella J. Lugtenburg
Consulting or Advisory Role - Celgene; Janssen-Cilag; Mundipharma; Roche/Genentech; SERVIER; Takeda
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Peter de Nully Brown
Consulting or Advisory Role - Gilead Sciences; Roche
Speakers' Bureau - Bayer
 
Bronno van der Holt
No Relationships to Disclose
 
Francesco D'Amore
Honoraria - Bayer; CTI; Kyowa Hakko Kirin; SERVIER; Takeda
Research Funding - Amgen; Roche; Sanofi; Takeda
 
Harry R Koene
No Relationships to Disclose
 
Henriette W Berenschot
Consulting or Advisory Role - Roche
 
Rob Fijnheer
No Relationships to Disclose
 
Olaf Loosveld
No Relationships to Disclose
 
Lara H Bohmer
No Relationships to Disclose
 
Hans Pruijt
Honoraria - Gilead Sciences; Roche
 
Gregor Verhoef
No Relationships to Disclose
 
Mels Hoogendoorn
Consulting or Advisory Role - Gilead Sciences; Novartis
 
Romko de Kan
No Relationships to Disclose
 
Gustaaf Willem Van Imhoff
No Relationships to Disclose
 
Christel van Hooije
No Relationships to Disclose
 
King H Lam
No Relationships to Disclose
 
Bart de Keizer
No Relationships to Disclose
 
Daphne de Jong
Consulting or Advisory Role - Celgene; Gilead Sciences
Research Funding - Celgene
 
Otto S. Hoekstra
No Relationships to Disclose
 
Josee M Zijlstra
Consulting or Advisory Role - Gilead Sciences; Roche
Research Funding - Roche